NEUROGEN CORP (NRGN) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 82 transactions totaling $471.3K, demonstrating a bearish sentiment with -$471.3K in net insider flow. The most recent transaction on Aug 30, 2010 involved a purchase of 5,600,000 shares valued at $0.
No significant insider buying has been recorded for NRGN in the recent period.
No significant insider selling has been recorded for NRGN in the recent period.
Based on recent SEC filings, insider sentiment for NRGN is bearish with an Insider Alignment Score of 0/100 and a net flow of -$471.3K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at NEUROGEN CORP (NRGN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading NRGN stock, having executed 82 transactions in the past 90 days. The most active insider is Alan Hutchison (Executive), who has made 64 transactions totaling $453.9K.
Get notified when executives and directors at NRGN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 30, 2010 | Andrew Stack W. | Executive | Purchase | 5,600,000 | $N/A | $0 | |
| Dec 23, 2009 | &. Co Warburg Pincus | Executive | Other | 13,571,411 | $N/A | $0 | |
| Dec 23, 2009 | Hen Stewart | Executive | Other | 13,571,411 | $N/A | $0 | |
| Jul 25, 2008 | Baker Felix | Executive | Conversion | 257,504 | $N/A | $0 | |
| Jul 25, 2008 | Baker Felix | Executive | Conversion | 125,112 | $N/A | $0 | |
| Jul 25, 2008 | Baker Felix | Executive | Conversion | 1,371,162 | $N/A | $0 | |
| Jul 25, 2008 | Baker Felix | Executive | Conversion | 1,304,550 | $N/A | $0 | |
| Jul 25, 2008 | Landy Joseph | Executive | Conversion | 4,999,982 | $N/A | $0 | |
| Jul 25, 2008 | S. Leff Jonathan | Executive | Conversion | 4,999,982 | $N/A | $0 | |
| Jul 25, 2008 | Hen Stewart | Executive | Conversion | 4,999,982 | $N/A | $0 | |
| Jul 25, 2008 | Simon John | Executive | Conversion | 249,990 | $N/A | $0 | |
| Jul 25, 2008 | Hen Stewart | Executive | Conversion | 4,999,982 | $N/A | $0 | |
| Jun 11, 2007 | L. Chenard Bertrand | Executive | Sale | 3,851 | $7.92 | $30.5K | |
| Apr 27, 2007 | Hutchison Alan | Executive | Sale | 200 | $6.90 | $1.4K | |
| Apr 27, 2007 | Hutchison Alan | Executive | Sale | 200 | $6.88 | $1.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 64 | $471.3K | 97.3% |
Award(A) | 1 | $13.1K | 2.7% |
Purchase(P) | 1 | $0 | 0.0% |
Other(J) | 7 | $0 | 0.0% |
Conversion(C) | 9 | $0 | 0.0% |
Insider selling pressure at NEUROGEN CORP has increased, with 11 insiders executing 82 transactions across all time. Total sales of $471.3K significantly outpace purchases of $0, resulting in a net outflow of $471.3K. This selling activity appears largely discretionary, which may warrant closer attention from investors.